Aclasta anbefales ikke til patienter med svær nedsat nyrefunktion (kreatininclearance < 35 ml/ min) på grund af manglende klinisk erfaring i denne patientgruppe.
Aclasta is not recommended for patients with severe renal impairment (creatinine clearance < 35 ml/ min) due to lack of adequate clinical experience in this population.